AR066812A1 - Vector poxvirus recombinante de mapache (rrcnv) vacuna recombinante porcina y metodos para inducir un respuesta inmune contra el virus del sindrome reproductivo y respiratorio de porcinos y para prevenir el sindrome reproductivo y respiratorio de porcino y el sindrome de desmedro multisistemico post - Google Patents

Vector poxvirus recombinante de mapache (rrcnv) vacuna recombinante porcina y metodos para inducir un respuesta inmune contra el virus del sindrome reproductivo y respiratorio de porcinos y para prevenir el sindrome reproductivo y respiratorio de porcino y el sindrome de desmedro multisistemico post

Info

Publication number
AR066812A1
AR066812A1 ARP080102315A ARP080102315A AR066812A1 AR 066812 A1 AR066812 A1 AR 066812A1 AR P080102315 A ARP080102315 A AR P080102315A AR P080102315 A ARP080102315 A AR P080102315A AR 066812 A1 AR066812 A1 AR 066812A1
Authority
AR
Argentina
Prior art keywords
reproductive
recombinant
respiratory syndrome
syrdrometrical
mapache
Prior art date
Application number
ARP080102315A
Other languages
English (en)
Inventor
Stephen Qitu Wu
Michael A Gill
Hsien-Jue Chu
Original Assignee
Wyeth Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Wyeth Corp filed Critical Wyeth Corp
Publication of AR066812A1 publication Critical patent/AR066812A1/es

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • C12N15/63Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/85Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
    • C12N15/86Viral vectors
    • C12N15/863Poxviral vectors, e.g. entomopoxvirus
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • C12N15/63Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/85Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
    • C12N15/86Viral vectors
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00Drugs for genital or sexual disorders; Contraceptives
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • C12N15/11DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/10Transferases (2.)
    • C12N9/12Transferases (2.) transferring phosphorus containing groups, e.g. kinases (2.7)
    • C12N9/1205Phosphotransferases with an alcohol group as acceptor (2.7.1), e.g. protein kinases
    • C12N9/1211Thymidine kinase (2.7.1.21)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K2039/51Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/525Virus
    • A61K2039/5256Virus expressing foreign proteins
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011Details
    • C12N2710/24011Poxviridae
    • C12N2710/24041Use of virus, viral particle or viral elements as a vector
    • C12N2710/24043Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2750/00MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssDNA viruses
    • C12N2750/00011Details
    • C12N2750/10011Circoviridae
    • C12N2750/10034Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2770/00MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
    • C12N2770/00011Details
    • C12N2770/10011Arteriviridae
    • C12N2770/10034Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Biomedical Technology (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Biotechnology (AREA)
  • Molecular Biology (AREA)
  • Medicinal Chemistry (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • Plant Pathology (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Physics & Mathematics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biophysics (AREA)
  • Virology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Pulmonology (AREA)
  • Reproductive Health (AREA)
  • Immunology (AREA)
  • Endocrinology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

Una vacuna del vector poxvirus recombinante de mapache en el que el vector expresa una o más proteínas antigénicas codificadas por multiples cuadros de lectura abiertos, preferiblemente el ORF5, el ORF6 o el ORF3/ORF4/ORF7, de una o más de las cepas del virus del síndrome reproductivo y respiratorio de porcino solo o en combinacion con un cuadro de lectura abierto del circovirus porcino tipo 2 (PCV-2), preferiblemente ORF2, en los sitios de la hemaglutinina (ha) y/o timidina quinasa (tk).
ARP080102315A 2007-05-30 2008-06-02 Vector poxvirus recombinante de mapache (rrcnv) vacuna recombinante porcina y metodos para inducir un respuesta inmune contra el virus del sindrome reproductivo y respiratorio de porcinos y para prevenir el sindrome reproductivo y respiratorio de porcino y el sindrome de desmedro multisistemico post AR066812A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US93242107P 2007-05-30 2007-05-30

Publications (1)

Publication Number Publication Date
AR066812A1 true AR066812A1 (es) 2009-09-16

Family

ID=40088500

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP080102315A AR066812A1 (es) 2007-05-30 2008-06-02 Vector poxvirus recombinante de mapache (rrcnv) vacuna recombinante porcina y metodos para inducir un respuesta inmune contra el virus del sindrome reproductivo y respiratorio de porcinos y para prevenir el sindrome reproductivo y respiratorio de porcino y el sindrome de desmedro multisistemico post

Country Status (15)

Country Link
US (1) US20080299141A1 (es)
EP (1) EP2148928A2 (es)
JP (1) JP2010528604A (es)
KR (1) KR20100025529A (es)
CN (1) CN101730742A (es)
AR (1) AR066812A1 (es)
AU (1) AU2008294036A1 (es)
BR (1) BRPI0812124A2 (es)
CA (1) CA2687026A1 (es)
CL (1) CL2008001557A1 (es)
CO (1) CO6241171A2 (es)
MX (1) MX2009012793A (es)
TW (1) TW200909578A (es)
WO (1) WO2009029130A2 (es)
ZA (1) ZA200908394B (es)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2010065140A2 (en) * 2008-12-05 2010-06-10 Osorio Jorge E Recombinant raccoon pox virus vaccine against highly pathogenic avian influenza
CN103298346A (zh) * 2010-12-22 2013-09-11 巴斯夫欧洲公司 用于增加植物健康的农用化学品混合物
CA2837375C (en) * 2011-06-01 2019-07-16 Merial Limited Needle-free administration of prrsv vaccines
CN102488895A (zh) * 2011-12-30 2012-06-13 重庆大学 一种猪圆环病毒、猪细小病毒、猪繁殖与呼吸综合症病毒三联病毒样颗粒疫苗及其制备方法
CN104211783B (zh) * 2013-05-22 2017-11-07 青岛明勤生物科技有限公司 一种蓝耳病亚单位疫苗的制备
CN110025781B (zh) * 2019-04-25 2022-09-20 杭州牧达智能科技有限公司 一种疫苗组合物及其制备方法

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH03503482A (ja) * 1988-02-12 1991-08-08 コモンウェルス・サイエンティフィック・アンド・インダストリアル・リサーチ・オーガナイゼーション ポックスウイルスベクター
US6241989B1 (en) * 1991-07-09 2001-06-05 Cornell Research Foundation, Inc. Recombinant multivalent viral vaccine
US7087234B1 (en) * 1991-07-09 2006-08-08 Cornell Research Foundation, Inc. Recombinant multivalent viral vaccine
US5695766A (en) * 1992-10-30 1997-12-09 Iowa State University Research Foundation Highly virulent porcine reproductive and respiratory syndrome viruses which produce lesions in pigs and vaccines that protect pigs against said syndrome
FR2781159B1 (fr) * 1998-07-06 2000-10-06 Merial Sas Vaccin circovirus et parvovirus porcin
US6391314B1 (en) * 1997-10-03 2002-05-21 Merial Porcine circoviruses vaccines diagnostic reagents
US6294176B1 (en) * 1998-07-10 2001-09-25 Schering-Plough Veterinary Corp. Recombinant raccoonpox virus and uses thereof as a vaccine in mammalian and avian species
CA2409874A1 (en) * 2000-05-24 2001-11-29 Merial Porcine reproductive and respiratory syndrome virus (prrsv) recombinant avipoxvirus vaccine
US7740863B2 (en) * 2001-04-06 2010-06-22 Merial Recombinant vaccine against West Nile Virus
US7276353B2 (en) * 2001-12-12 2007-10-02 Virginia Tech Intellectual Properties, Inc. Chimeric infectious DNA clones, chimeric porcine circoviruses and uses thereof
JP2006503800A (ja) * 2002-03-13 2006-02-02 メルク エンド カムパニー インコーポレーテッド Hivに対する強化された免疫応答を誘導する方法

Also Published As

Publication number Publication date
CN101730742A (zh) 2010-06-09
CO6241171A2 (es) 2011-01-20
US20080299141A1 (en) 2008-12-04
EP2148928A2 (en) 2010-02-03
CA2687026A1 (en) 2009-03-05
AU2008294036A1 (en) 2009-03-05
TW200909578A (en) 2009-03-01
KR20100025529A (ko) 2010-03-09
BRPI0812124A2 (pt) 2014-10-14
CL2008001557A1 (es) 2008-08-22
WO2009029130A2 (en) 2009-03-05
MX2009012793A (es) 2010-03-26
WO2009029130A3 (en) 2009-05-07
ZA200908394B (en) 2010-08-25
JP2010528604A (ja) 2010-08-26

Similar Documents

Publication Publication Date Title
AR066812A1 (es) Vector poxvirus recombinante de mapache (rrcnv) vacuna recombinante porcina y metodos para inducir un respuesta inmune contra el virus del sindrome reproductivo y respiratorio de porcinos y para prevenir el sindrome reproductivo y respiratorio de porcino y el sindrome de desmedro multisistemico post
CR20190127A (es) Métodos para detectar aav
AR058870A1 (es) Composiciones inmunogenicas de pcv2 multivalentes y metodos de producir composiciones de este tipo
ES2421543T3 (es) Método para la preparación de virus y proteínas del PRRS, y kits de pruebas de diagnóstico para su detección
AR053327A1 (es) Vacunas mejoradas del vsrrp, metodo para preparar y su uso
NO20076360L (no) Dengue serotype 2 attenuert stamme
EA201170813A1 (ru) Способы и композиции на основе pcv2 для лечения свиней
AR064888A1 (es) Celulas no simias para el crecimiento del virus del sindrome reproductor y respiratorio porcino (prrs)
WO2010025109A8 (en) Vaccine against highly pathogenic porcine reproductive and respiratory syndrome (hp prrs)
AR053913A1 (es) Cepa atenuada de dengue serotipo 1
ES2627330T3 (es) Uso de JAZ5a para mejorar la resistencia a la sequía en una planta
AR057213A1 (es) Acidos nucleicos que codifican secuencias tgev y prrsv para la expresion mejorada de secuencias prrsv
AR059772A1 (es) Composiciones que incuyen hemaglutinina metodos de elaboracion y metodos de uso de las mismas
CU20090169A7 (es) Métodos y composiciones para virus vivos atenuados
EA200801756A1 (ru) Противогриппозные вакцины, содержащие гемагглютинин и белки матрикса
UY29915A1 (es) Vacuna combinada que comprende un virus atenuado de la diarrea viral bovina
CR9076A (es) Metodo y materiales para conferir resistencia a las pestes y patogenos de plantas
Hu et al. Pathogenicity and distribution of highly pathogenic porcine reproductive and respiratory syndrome virus in pigs
MY163972A (en) Attenuated recombinant newcastle disease virus and vaccine containing the same
EP1794329A4 (en) ISOLATES OF PORCINE RESPIRATORY DYSGENESIS SYNDROME (SDRP), AND METHODS OF USE
MX2013013906A (es) Vacunas combinadas para prevencion de infecciones por virus porcino.
CO2018003460A2 (es) Vacunas de partículas tipo virus (vlp) contra el parvovirus canino (cpv) y sus usos
AR066449A1 (es) Metodo para la purificacion de un virus o antigeno viral, por ultracentrifugacion continua, usando formulaciones de soluciones de sacarosa
PH12018501368A1 (en) M hyo multivalent vaccine and uses thereof
CO6290700A2 (es) Una vacuna que comprende una emulsion y una bacterina tratada con calor que comprende una suspension de la bacteria muerta

Legal Events

Date Code Title Description
FA Abandonment or withdrawal